Hairy Curtain Crust

Metadata

Regulatory Status

China (People’s Republic)

• TCM Pharmacopoeia: Not listed as an official monograph.
• Folk Medicine: The fruiting body has been used in Chinese folk medicine for the treatment of cancers. S. hirsutum is also the host fungus parasitized by Tremella aurantia (golden ear mushroom/Jin’er), a heterogeneous basidiocarp used as both food and folk medicine.
• Commercial Status: Not commercially marketed as a standalone medicinal product.

Korea

• Traditional Use: Used in Korean folk medicine. Korean wild specimens have been the subject of bioactivity-guided fractionation studies identifying antibacterial sterols.
• Research Status: Subject of active pharmacological research at Korean institutions.

United States

• FDA Status: No GRAS determination. Not marketed as a dietary supplement.
• Research Interest: Known in natural products research as a prolific source of sesquiterpenoid secondary metabolites.

European Union

• Status: Not authorized as a food or food supplement. Not evaluated by EMA/HMPC.
• Mycological Status: Well-known and widely distributed wood-decay fungus across European forests.

Conditions & Indications

Primary Indications (Preclinical Evidence)

• Antimicrobial infections, including MRSA — Stereumamides A and D (novel sesquiterpene-amino acid quaternary ammonium hybrids) show antibacterial activity against Escherichia coli, Staphylococcus aureus, and Salmonella typhimurium. Benzoate derivatives and hirsutane sesquiterpenoids demonstrate antimicrobial effects against methicillin-resistant Staphylococcus aureus (MRSA) with MIC values of 25.0 micrograms/mL. Epidioxysterols show antitubercular activity against Mycobacterium tuberculosis.
• Cancer (preclinical cytotoxicity) — Multiple compound classes from S. hirsutum demonstrate cytotoxicity against cancer cell lines. Hirsutane sesquiterpenoids show IC50 values of 10-50 micromolar against A549 (lung) and HepG2 (hepatocellular) cancer cell lines. The fruiting body has been used in Chinese and Korean folk medicine for cancer treatment.
• Atherosclerosis and cardiovascular protection — Ethanol and methanol extracts demonstrate anti-atherosclerotic bioactivity through antioxidant and anti-inflammatory mechanisms. EtOH extracts show DPPH free radical scavenging activity of 45.84% at 2 mg/mL concentration.

Secondary Indications (In Vitro Evidence)

• Immunomodulation (immunosuppression) — Sterhirsutins E and G demonstrate immunosuppressant bioactivity dependent on the ether bond between C-15’ and C-16’. Sterhirsutin G may be a potential drug for autoimmune diseases through its ability to inhibit RLR-mediated (RIG-I-like receptor) antiviral signaling pathways.
• Antifungal activity — Extracts demonstrate antifungal activity against various fungal pathogens, contributing to the species’ ecological role as a competitive wood-decay organism.
• Antioxidant defense — Phenolic compounds and flavonoids in S. hirsutum extracts (54.17 mg GAE/g total phenols, 48.46 mg CE/g total flavonoids in some preparations) contribute to significant antioxidant capacity, relevant to oxidative stress-related chronic diseases.

Emerging/Preclinical Indications

• Acetylcholinesterase inhibition — Phenolic and fatty acid constituents demonstrate acetylcholinesterase (AChE) inhibitory activity in vitro, suggesting potential relevance to neurodegenerative disease research, particularly Alzheimer’s disease.
• Genoprotective effects — Extracts show DNA-protective properties against oxidative damage in the comet assay, suggesting potential chemopreventive applications.
• Antiviral activity — Sterhirsutin G inhibits RLR-mediated antiviral signaling, a mechanism that could be relevant to autoimmune conditions where antiviral innate immune pathways are aberrantly activated.

Mechanism of Action

Primary Mechanisms

1. Hirsutane sesquiterpenoid antimicrobial and cytotoxic activity Stereum hirsutum is a prolific producer of hirsutane-type tricyclic sesquiterpenoids, a structural class named after this species. These compounds, including hirsutenols A-F and hirsutic acids C-E and N, exert antimicrobial activity through disruption of microbial cell membrane integrity and interference with essential metabolic enzymes. The cytotoxic activity against cancer cell lines (A549, HepG2) involves induction of apoptosis, though the specific molecular targets and signaling pathways remain under investigation. The hirsutuminoids A-Q represent a newer class of linear triquinane sesquiterpenoids with additional structural diversity.

2. Stereumamide quaternary ammonium antibacterial mechanism Stereumamides A-D are unique natural products representing the first known sesquiterpene-amino acid quaternary ammonium hybrids from a fungal source. Quaternary ammonium compounds (QACs) are well-established antibacterial agents that disrupt bacterial cell membranes by interacting with the lipid bilayer through their permanently charged nitrogen. The combination of a sesquiterpene scaffold with a QAC pharmacophore in a single natural product molecule is unprecedented and confers broad-spectrum antibacterial activity including against MRSA.

3. Sterhirsutin immunosuppressant activity Sterhirsutins A-D are rare heterodimeric sesquiterpenes that exhibit immunosuppressant activity. Sterhirsutin G specifically inhibits RIG-I-like receptor (RLR)-mediated antiviral innate immune signaling, a pathway involving detection of viral RNA by cytoplasmic pattern recognition receptors. This mechanism is distinct from conventional immunosuppressants and potentially relevant to autoimmune conditions characterized by aberrant innate immune activation.

Secondary Mechanisms

• Epidioxysterol anti-inflammatory activity: 5alpha,8alpha-epidioxyergosta-6,22-dien-3beta-ol and related ergosterol peroxides suppress inflammatory responses through inhibition of NF-kB signaling and reduction of pro-inflammatory cytokine production. The antitubercular activity of these compounds may involve disruption of mycobacterial cell wall synthesis or membrane integrity.
• Phenolic antioxidant mechanisms: Phenolic compounds and flavonoids act as free radical scavengers (DPPH, ABTS, superoxide), metal ion chelators (Fe2+, Cu2+), and inhibitors of lipid peroxidation, collectively reducing oxidative stress and contributing to the anti-atherosclerotic effects.
• Acetylenic compound phytotoxicity: Acetylenic aromatic compounds from S. hirsutum demonstrate phytotoxic activity, reflecting the species’ ecological strategy for competitive wood colonization and territory defense.

Clinical Evidence Summary

No human clinical trials have been published for Stereum hirsutum. All pharmacological evidence derives from in vitro studies, compound isolation and characterization, and animal models.

Key Research Studies

Evidence Limitations

• No human clinical trials for any indication.
• Most studies focus on isolated compounds from fermented mycelium rather than traditional preparations or whole extracts, limiting relevance to folk medicine validation.
• The species is not consumed directly as food or supplement; its primary value is as a source of bioactive natural products for drug discovery.
• In vitro cytotoxicity against cancer cell lines does not predict clinical anticancer efficacy.
• MIC values for antimicrobial activity (25 micrograms/mL against MRSA) are moderate and may not achieve therapeutic concentrations in vivo without formulation optimization.
• Traditional use documentation for cancer treatment is anecdotal without controlled clinical observation.
• Publication focus on novel compound isolation creates a bias toward structural chemistry over pharmacological validation.

Safety Profile

General Assessment

Stereum hirsutum is not a species consumed as food, and formal safety assessment data are limited. The fruiting body is too tough and leathery for direct consumption. Traditional use has been as a medicinal preparation (decoction or extract) rather than a food product. The presence of potent bioactive compounds with immunosuppressant and cytotoxic activities warrants significant caution.

Contraindications

• Pregnancy and lactation: No safety data available. The presence of cytotoxic compounds (sesquiterpenoids with IC50 10-50 micromolar) and immunosuppressant sterhirsutins creates unacceptable theoretical risk.
• Autoimmune conditions: While sterhirsutins show immunosuppressant activity that could theoretically benefit autoimmune conditions, the lack of clinical data on dose, safety, and efficacy means self-treatment is not appropriate.
• Immunocompromised patients: Immunosuppressant sterhirsutins could exacerbate immunodeficiency.

Drug Interactions

No clinical drug interactions documented. Theoretical interactions include:

• Immunosuppressants (cyclosporine, tacrolimus): Sterhirsutins may have additive immunosuppressive effects. Severity: Theoretical.
• Anticoagulants: Some sesquiterpenoids may affect platelet function. Severity: Theoretical.
• Antibiotics: Stereumamides may interact synergistically or antagonistically with conventional antibiotics. Severity: Unknown.

Side Effects

No systematically documented side effects due to the absence of human consumption data. Based on the metabolite profile, potential concerns include gastrointestinal irritation from sesquiterpenoid content and immunosuppression at high doses.

Clinical Dosage

Traditional Preparation

• Folk medicine decoction: Specific dosing protocols are not standardized in the available literature. Traditional use involved preparation of the fruiting body as a decoction for cancer treatment in Chinese and Korean folk medicine.
• Not consumed directly: The tough, leathery fruiting body is not suitable for direct consumption.

Research Context

• Dosing guidelines for human use cannot be established due to the absence of human clinical trials.
• Research on isolated compounds uses micromolar concentrations in vitro; translation to human oral dosing is not established.
• Any therapeutic application should be considered strictly experimental.

Sources

• Yun BS, Lee IK, Kim JP, Yoo ID. New benzoate derivatives and hirsutane type sesquiterpenoids with antimicrobial activity and cytotoxicity from the solid-state fermented rice by the medicinal mushroom Stereum hirsutum. Fitoterapia. 2013;91:294-300
• Li L, Peng XR, Shi L, et al. Four novel antibacterial sesquiterpene-alpha-amino acid quaternary ammonium hybrids from the mycelium of mushroom Stereum hirsutum. Fitoterapia. 2018;128:174-178
• Hosoya T, Yamamoto Y, Kurihara Y, et al. Structure elucidation of linear triquinane sesquiterpenoids, hirsutuminoids A-Q, from the fungus Stereum hirsutum and their activities. Phytochemistry. 2022;200:113233
• Miskovic J, Karaman M, Raki T, et al. Mushroom species Stereum hirsutum as natural source of phenolics and fatty acids as antioxidants and acetylcholinesterase inhibitors. Chem Biodivers. 2021;18(12):e202100409
• Amiri S, Nicknam MH, Monsef Esfahani HR, et al. Bioactivity of EtOH and MeOH extracts of basidiomycetes mushroom (Stereum hirsutum) on atherosclerosis. Arch Razi Inst. 2021;76(4):1053-1064
• Kim JH, Lee JS, Lee KR, et al. Identification of antibacterial sterols from Korean wild mushroom Daedaleopsis confragosa via bioactivity- and LC-MS/MS profile-guided fractionation. Molecules. 2022;27(6):1865
• Liu L, Shi L, Peng XR, et al. In depth natural product discovery from the basidiomycetes Stereum species. Microorganisms. 2020;8(7):1049
• Ayer WA, Cruz ER. Acetylenic aromatic compounds from Stereum hirsutum. Phytochemistry. 1999;53(5):613-616
• Haraguchi H, Kataoka S, Okamoto S, Hanafi M, Shibata K. Antimicrobial triterpenes from Ilex integra and the mechanism of antifungal action. Phytother Res. 1999;13(2):151-156
• Weber D, Sterner O, Anke T, et al. Antibiotics from Stereum hirsutum. Z Naturforsch C J Biosci. 2004;59(11-12):822-825

Connections

• Compare with Turkey Tail (Trametes versicolor) — often confused with S. hirsutum (hence the common name “False Turkey Tail”); Turkey Tail has far stronger clinical evidence for immunomodulation through PSK/PSP polysaccharides, while S. hirsutum is distinguished by its sesquiterpenoid chemistry and antimicrobial activity
• Compare with Trametes hirsuta — another “hairy” polypore bracket fungus sometimes confused with S. hirsutum; both share antimicrobial properties but belong to different orders (Russulales vs. Polyporales)
• The hirsutane sesquiterpenoid class named after this species represents a structural scaffold found across multiple fungal genera, connecting S. hirsutum to the broader natural products pharmacology of basidiomycete fungi
• The immunosuppressant sterhirsutins contrast with the immune-stimulatory beta-glucans of Reishi and Turkey Tail, representing the opposite end of the immunomodulatory spectrum — a distinction critical for appropriate clinical application
• The anti-atherosclerotic potential through antioxidant and anti-inflammatory mechanisms parallels cardiovascular research on Reishi triterpenoids, though through different compound classes (sesquiterpenoids vs. lanostane triterpenoids)
• Fomes fomentarius shares the wood-decay ecological niche and traditional medicinal use heritage across European and Asian folk medicine traditions